Angel Capital Association recognizes innovation in organ preservation and transplantation. BMI OrganBank is proud to announce that it has received the 2026 Luis Villalobos Award for Innovation in Life Sciences, presented by the Angel Capital Association (ACA) during the 2026 Summit of Angel Investing. The Luis Villalobos Award recognizes…

Ahead of her participation in Aspen Ideas: Health this week, our CEO and Co-Founder, Carrie DiMarzio, was interviewed by The Aspen Institute about how transplantation could be fundamentally reimagined to give clinicians more time and better information. The interview was featured in the Aspen…

Why the transplant system spends more and delivers less than it should The United States spends tens of billions of dollars each year managing kidney failure, largely through ongoing dialysis care. Yet, kidney transplantation, which improves survival and lowers long-term costs, reaches only a…

Every year, nearly 100,000 people wait for a kidney that never comes. Not because donors don’t exist or because surgeons aren’t ready.But because the system between donation and transplant is constrained by time, limited real-time data, and tools that no longer match the realities…

Compared to hypothermic machine preservation, OrganBank Kidney showed more consistent early graft performance in a controlled preclinical transplant model BMI OrganBank recently presented new preclinical data at the American Society of Transplant Surgeons (ASTS) Winter Symposium evaluating its OrganBank Kidney platform in a controlled, head-to-head transplant…

Innovation Quarter has recognized BMI OrganBank as one of nine life science companies in the iQ to watch in 2026, highlighting the continued growth of Winston-Salem’s regenerative medicine and biotechnology ecosystem. The annual feature spotlights companies advancing science, technology, and translational innovation across the Innovation Quarter. This year’s…

BMI OrganBank is pleased to begin 2026 by welcoming two new investors into its growing community: Mid Atlantic Bio Angels (BioAngels) and Sonnerie VC. Both groups bring experience supporting early-stage healthcare and life science companies and share a commitment to advancing impactful innovation in regulated markets. BMI…

At BMI OrganBank®, the work begins with Carrie DiMarzio, co-founder and CEO, whose career spans precision engineering, biomedical research, and clinical technology development. A co-inventor and peer-reviewed author, Carrie brings technical rigor and systems-level thinking to one of medicine’s most complex challenges: how donated organs…

NEW YORK, Sept. 22, 2025 /PRNewswire/ — The National Kidney Foundation (NKF) announced today that its Innovation Fund has invested in BMI OrganBank, a Winston-Salem, NC–based medical device company pioneering next-generation organ preservation and assessment technologies. The funding will be used to finalize preparations for BMI OrganBank’s…

BMI OrganBank is developing novel medical devices with potential to significantly reduce the waitlist for lifesaving organ transplants, beginning with kidneys FDA Breakthrough Device Designation secures additional FDA engagement in advance of clinical studies planned for next year WINSTON-SALEM, N.C., Aug. 4, 2025 /PRNewswire/ — BMI…

BMI OrganBank® is delighted to report the publication of new research findings in the prestigious journal Nature Biomedical Engineering – “Evolving adeno-associated viruses for gene transfer to the kidney via cross-species cycling of capsid libraries.” As part of this study, researchers from the laboratories of Dr. Aravind…

The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has announced a groundbreaking investment of $2.5 million in the region’s regenerative medicine industry through its inaugural Ecosystem Building Grant program. This milestone underscores PTRME’s leadership in regenerative medicine and…